Mead Johnson Nutrition Company (NYSE:MJN) has been upgraded from Underperform to Outperform in a statement by CLSA earlier today.
- Updated: September 18, 2016
CLSA has upgraded Mead Johnson Nutrition Company(NYSE:MJN) from Underperform to Outperform in a statement released on 8/03/2016.
Having a price of $87.29, Mead Johnson Nutrition Company (NYSE:MJN) traded 0.70% lower on the day. The last close is up 9.38% relative to the 200-day moving average, compared with the S&P 500 which has decreased -0.01% over the same time. MJN has logged a 50-day moving average of $85.70 and 200-day moving average of $84.70. Volume of trade was was up over the average, with 1,625,937 shares of MJN changing hands over the typical 1,477,330 shares.
See Graphic Below:
Mead Johnson Nutrition Company has a one-year low of $65.53 and a one-year high of $94.40 with a price-earnings ratio of 29 and has a market capitalization of $0.0.
In addition to CLSA reporting it’s price target, a total of 12 analysts have issued a report on MJN. The average target is $82.00 with 0 rating the stock a strong buy, 0 rating the company a buy, 0 analysts rating the stock a hold, 0 rating the company to underperform, and lastly 0 analystsrating the company as sell.
About Mead Johnson Nutrition Company (NYSE:MJN)
Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company’s Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children, and expectant and nursing mothers. The Company markets its portfolio of approximately 70 products to mothers, healthcare professionals and retailers in over 50 countries in Asia, North America, and Latin America and Europe.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.